CFTR and cystic fibrosis: We found that DMF reduced the inflammatory response to LPS stimulation in both CF and non-CF bronchial epithelial cells, both as co-treatment and therapy, and restored LPS-mediated decrease of TrikaftaTM-mediated CFTR function in CF cells bearing the most common mutation, c.1521_1523delCTT (F508del).